Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer

Li,Jian‑Wang; Huang,Chun‑Zhen; Li,Jian‑Hua; Yuan,Jian‑Hua; Chen,Qiong‑Hui; Zhang,Wei‑Fang; Xu,Zhen‑Sheng; Liu,Ying‑Ping; Li,Yong; Zhan,Mei‑Xiao; Lu,Li‑Gong

doi:10.3892/or.2018.6581

Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer

Authors:
- Jian‑Wang Li
- Chun‑Zhen Huang
- Jian‑Hua Li
- Jian‑Hua Yuan
- Qiong‑Hui Chen
- Wei‑Fang Zhang
- Zhen‑Sheng Xu
- Ying‑Ping Liu
- Yong Li
- Mei‑Xiao Zhan
- Li‑Gong Lu
View Affiliations

Affiliations: Department of Oncology, Central South University Xiangya School of Medicine Affiliated Haikou Hospital/ Haikou People's Hospital, Haikou, Hainan 570208, P.R. China, Department of General Surgery, Fuzhou People's Hospital, Fuzhou, Jiangxi 344000, P.R. China, Interventional Radiology Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong 519000, P.R. China
Published online on: July 17, 2018 https://doi.org/10.3892/or.2018.6581
Pages: 2215-2223

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metadherin (MTDH) is a multifunctional oncogene involved in tumor cell migration and metastasis through regulating a number of oncogenic signaling pathways in various human malignancies. Previous studies have demonstrated that MTDH is overexpressed in human colorectal cancer (CRC) and associated with cancer progression and a poor prognosis. However, the underlying mechanisms remain largely unknown. The present study investigated the expression and role of MTDH in CRC cells as well as the underlying mechanism of this. Western blot analysis and quantitative polymerase chain reaction were conducted to determine protein and mRNA expression of MTDH in three human CRC cell lines. A short hairpin RNA (shRNA) targeting MTDH was introduced into CRC HCT116 cells to stably inhibit MTDH expression. A Cell Counting Kit‑8 assay, colony formation assay, Transwell assay and flow cytometry were used to investigate the effect of MTDH‑knockdown on cell proliferation, migration, apoptosis and cell cycle arrest. Western blotting was performed to examine the protein expression levels of cell growth‑ and apoptosis‑associated genes. The results demonstrated that MTDH was commonly expressed in CRC cell lines. MTDH silencing significantly suppressed cell growth, colony forming ability and migration while inducing the apoptosis of HCT116 cells. In addition, MTDH depletion induced S phase cell cycle arrest in HCT116 cells. Mechanistically, knockdown of MTDH markedly downregulated the expression of phosphorylated protein kinase B, c‑Myc, proliferating cell nuclear antigen and B‑cell lymphoma 2 (Bcl‑2) protein in HCT116 cells, and the expression of p53 and Bcl‑2‑associated X protein was significantly increased compared with the negative control shRNA group (P<0.05), suggesting that MTDH may function through the expression of numerous types of apoptosis‑associated and signaling channel proteins in CRC cells. Taken together, these data indicated that MTDH may serve as a biomarker and candidate therapeutic target for CRC.

View Figures

View References

1	Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Korakakis E, Din FV, Porteous ME, Dunlop MG and Campbell H: Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population. Eur J Cancer Prev. 23:8–17. 2014. View Article : Google Scholar : PubMed/NCBI
2	Akagi Y, Kinugasa T, Adachi Y and Shirouzu K: Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies. Mol Clin Oncol. 1:582–592. 2013. View Article : Google Scholar : PubMed/NCBI
3	Guo Y, Xu F, Lu T, Duan Z and Zhang Z: Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 38:904–910. 2012. View Article : Google Scholar : PubMed/NCBI
4	Lièvre A, Blons H and Laurent-Puig P: Oncogenic mutations as predictive factors in colorectal cancer. Oncogene. 29:3033–3043. 2010. View Article : Google Scholar : PubMed/NCBI
5	Grady WM and Pritchard CC: Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol. 42:124–139. 2014. View Article : Google Scholar : PubMed/NCBI
6	Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ and Fisher PB: Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
7	Hu G, Wei Y and Kang Y: The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res. 15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
8	Li M, Dai Y, Wang L and Li L: Astrocyte elevated gene-1 promotes the proliferation and invasion of breast cancer cells by activating the Wnt/β-catenin signaling pathway. Oncol Lett. 13:2385–2390. 2017. View Article : Google Scholar : PubMed/NCBI
9	Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X and Song Y: Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer. 111:355–364. 2014. View Article : Google Scholar : PubMed/NCBI
10	Zhu HD, Liao JZ, He XX and Li PY: The emerging role of astrocyte elevated gene in hepatocellular carcinoma (Review). Oncol Rep. 34:539–546. 2015. View Article : Google Scholar : PubMed/NCBI
11	Jung HI, Ahn T, Bae SH, Chung JC, Kim H, Chin S, Jeong D, Cho HD, Lee MS, Kim HC, et al: Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: An independent prognostic factor. Ann Surg Treat Res. 88:77–85. 2015. View Article : Google Scholar : PubMed/NCBI
12	Jian-bo X, Hui W, Yu-long H, Chang-hua Z, Long-juan Z, Shirong C and Wen-hua Z: Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol. 28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M and Maehara Y: Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer. 21:341–349. 2014. View Article : Google Scholar : PubMed/NCBI
14	Gnosa S, Shen YM, Wang CJ, Zhang H, Stratmann J, Arbman G and Sun XF: Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines. J Transl Med. 10:1092012. View Article : Google Scholar : PubMed/NCBI
15	Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K and Fisher PB: Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Res. 66:1509–1516. 2006. View Article : Google Scholar : PubMed/NCBI
16	Lee SG, Su ZZ, Emdad L, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA. 103:17390–17395. 2006. View Article : Google Scholar : PubMed/NCBI
17	Wei J, Li Z, Chen W, Ma C, Zhan F, Wu W and Peng Y: AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation. Cell Biol Int. 37:1016–1021. 2013. View Article : Google Scholar : PubMed/NCBI
18	Li PP, Feng LL, Chen N, Ge XL, Lv X, Lu K, Ding M, Yuan D and Wang X: Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Med Oncol. 32:212015. View Article : Google Scholar
19	Song H, Li C, Li R and Geng J: Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis. 25:1201–1209. 2010. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Wang F, Wang H, Sun X and Li M: Apoptosis-induction is a novel therapeutic strategy for gastrointestinal and liver cancers. Curr Gene Ther. 15:193–200. 2015. View Article : Google Scholar : PubMed/NCBI
22	Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ and Fisher PB: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002. View Article : Google Scholar : PubMed/NCBI
23	Sun S, Ke Z, Wang F, Li S, Chen W, Han A, Wang Z, Shi H, Wang LT and Chen X: Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol. 43:1051–1060. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical cancer and its correlation with angiogenesis. Asian Pac J Cancer Prev. 16:2277–2281. 2015. View Article : Google Scholar : PubMed/NCBI
25	Wang J, Chen X and Tong M: Knockdown of astrocyte elevated gene-1 inhibited cell growth and induced apoptosis and suppressed invasion in ovarian cancer cells. Gene. 616:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
26	Li WF, Ou Q, Dai H and Liu CA: Lentiviral-mediated short hairpin RNA knockdown of MTDH inhibits cell growth and induces apoptosis by regulating the PTEN/AKT pathway in hepatocellular carcinoma. Int J Mol Sci. 6:19419–19432. 2015. View Article : Google Scholar
27	Casimiro S, Fernandes A, Oliveira AG, Franco M, Pires R, Peres M, Matias M, Tato-Costa J, Guerra N, Ramos M, et al: Metadherin expression and lung relapse in patients with colorectal carcinoma. Clin Exp Metastasis. 31:689–696. 2014. View Article : Google Scholar : PubMed/NCBI
28	Shi X and Wang X: The role of MTDH/AEG-1 in the progression of cancer. Int J Clin Exp Med. 8:4795–4807. 2015.PubMed/NCBI
29	Millis SZ, Ikeda S, Reddy S, Gatalica Z and Kurzrock R: Landscape of phosphatedy- linositol-3-kinase pathway alterations across 19 784 diverse solid tumors. JAMA Oncol. 2:1565–1573. 2016. View Article : Google Scholar : PubMed/NCBI
30	Brown JS and Banerji U: Maximising the potential of AKT inhibitors as anti-cancer treatments. Pharmacol Ther. 172:101–105. 2017. View Article : Google Scholar : PubMed/NCBI
31	Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A, Lynch HT and Smyrk TC: AKT proto-oncogene over-expression is an early event during sporadic colon carcinogenesis. Carcinogenesis. 23:201–205. 2002. View Article : Google Scholar : PubMed/NCBI
32	Nesbit CE, Tersak JM and Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene. 18:3004–3016. 1999. View Article : Google Scholar : PubMed/NCBI
33	Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, Tamachi A, Tu WB and Penn LZ: MYC deregulation in primary human cancers. Genes. 8:E1512017. View Article : Google Scholar : PubMed/NCBI
34	Liu Z, He Q, Ding X, Zhao T, Zhao L and Wang A: SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells. Int J Biochem Cell Biol. 60:139–146. 2015. View Article : Google Scholar : PubMed/NCBI
35	Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene. 27:1114–1121. 2008. View Article : Google Scholar : PubMed/NCBI
36	Gregory MA, Qi Y and Hann SR: Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization. J Biol Chem. 278:51606–51612. 2003. View Article : Google Scholar : PubMed/NCBI
37	Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT and Armelin HA: c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. J Mol Endocrinol. 33:623–638. 2004. View Article : Google Scholar : PubMed/NCBI